Digital health for real-time monitoring of a national immunisation campaign in Indonesia: a large-scale effectiveness evaluation.
community child health
information technology
public health
quality in health care
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
10 12 2020
10 12 2020
Historique:
entrez:
11
12
2020
pubmed:
12
12
2020
medline:
15
5
2021
Statut:
epublish
Résumé
To assess the contribution of a digital health real-time monitoring platform towards the achievement of coverage targets during a national immunisation campaign in Indonesia. A digital health platform was introduced to facilitate real-time reporting and data visualisation. Health workers submitted reports of children immunised each day by geolocation using mobile phones. Automated reports were generated for programme managers at all levels to enable early responses to coverage gaps. Risk profiles were generated for each district to assess precampaign immunisation programme performance. Digital health platform use and progress towards targets were monitored continuously throughout the campaign. Study outcomes were total coverage and time to achieve full (100%) coverage. Kaplan-Meier, Cox and linear regression analyses were used to estimate the associations and outcomes after adjusting for district risk profiles. A complementary qualitative assessment explored user experiences and acceptance through interviews with vaccinators and programme managers in provinces and districts selected through multistage random sampling. Between August and December 2018, 6462 health facilities registered to use the digital health platform across 28 provinces and 395 districts. After adjusting for precampaign district risk profile and intracampaign delays due to vaccine hesitancy, districts with greater platform utilisation demonstrated higher coverage overall (R A digital health platform introduced for real-time monitoring of a national immunisation campaign in Indonesia was feasible, well liked and associated with improved problem solving and programme performance, particularly among districts affected by vaccine hesitancy. ISRCTN10850448.
Identifiants
pubmed: 33303436
pii: bmjopen-2020-038282
doi: 10.1136/bmjopen-2020-038282
pmc: PMC7733193
doi:
Substances chimiques
Vaccines
0
Banques de données
ISRCTN
['ISRCTN10850448']
Types de publication
Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e038282Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Epidemiology. 2010 Jul;21 Suppl 4:S64-70
pubmed: 20386104
Bull World Health Organ. 2014 Mar 1;92(3):220-5
pubmed: 24700982
Lancet. 2002 Apr 13;359(9314):1309-10
pubmed: 11965278
MMWR Morb Mortal Wkly Rep. 2016 Oct 07;65(39):1072-1076
pubmed: 27711034
Lancet. 2011 Jan 1;377(9759):85-95
pubmed: 20619886
Lancet Glob Health. 2017 Apr;5(4):e428-e438
pubmed: 28288747
Vaccine. 2017 Mar 7;35(10):1373-1379
pubmed: 28190744
Lancet Planet Health. 2019 Mar;3(3):e114-e115
pubmed: 30904105